European equities traded in the US as American depositary receipts were edging down on Thursday morning, declining 0.2% to 1,309.13 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by energy company Equinor (EQNR) and biotech company BioNTech (BNTX), which rose 1.9% and 1.3% respectively.
The decliners from continental Europe were led by pharmaceutical and chemical manufacturer Grifols (GRFS) and pharmaceutical giant Novo Nordisk (NVO), which dropped 4% and 3% respectively.
They were followed by telecoms and consumer electronics company Nokia (NOK), down 2.7%.
From the UK and Ireland, the gainers were led by software development firm Endava (DAVA) and oil and gas major Shell (SHEL), which rose 5.8% and 1.3% respectively.
The decliners from the UK and Ireland were led by biotech companies Silence Therapeutics (SLN) and Compass Pathways (CMPS), which lost 3.1% and 2.8% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。